Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Berkshire Hathaway Wannabe Turning Into A Quagmire For Investors also written by Antoine Gara
- Intel CEO to retire as chipmaker struggles with mobile also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- DuPont's Activist Response Has Perfect Formula To Counter Trian's Nelson Peltz also written by Antoine Gara
- Warren Buffett And CalSTRS Agree On Brian Moynihan's Performance At Bank Of America also written by Antoine Gara
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Ackman Expects 'Influence' in Air Products CEO Search also written by Antoine Gara
Login to comment.